News
New Data For Teva AJOVY® (fremanezumab-vfrm) Injection and ...
apnews.com
May 01, · “We are pleased to have an opportunity to share this important data with the neurology community which build upon our understanding of the efficacy and safety of AJOVY and AUSTEDO across various patient populations, and further demonstrate Teva’s commitment to the CNS space,” said Denisa Hurtukova, MD, VP, Head of North America Medical ...
Teva Presents New Analyses On Migraine Disability Outcome...
www.rttnews.com
"Migraine is more than just a headache and profoundly disrupts all aspects of life, including family life, social interactions and workplace success," said Denisa Hurtukova, MD, Vice President, Head of North America Medical Affairs.
Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection...
stockhouse.com
Jun 15, · “Migraine is the second leading cause of years lived with disability and imposes physical, emotional, and societal burdens worldwide,” said Denisa Hurtukova, MD, Vice President, Head of North America Medical Affairs.
Teva to Present New Data on AJOVY® (fremanezumab-vfrm ...
www.tevapharm.com
Jun 15, · “Migraine is the second leading cause of years lived with disability and imposes physical, emotional, and societal burdens worldwide,” said Denisa Hurtukova, MD, Vice President, Head of North America Medical Affairs.
sorted by relevance / date